On October 29, Gelonhui | Haisco Pharmaceutical Group (002653.SZ) released its third quarter report for 2024, achieving revenue of 2.751 billion yuan in the first three quarters, a year-on-year increase of 15.41%; net income attributable to shareholders of the listed company was 0.382 billion yuan, a year-on-year increase of 90.20%; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 0.215 billion yuan, a year-on-year increase of 44.55%; basic earnings per share was 0.3409 yuan.
海思科(002653.SZ)：前三季度净利润3.82亿元 同比增长90.20%
haisco pharmaceutical group (002653.SZ): net income of 0.382 billion yuan in the first three quarters, a year-on-year increase of 90.20%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated